Trial Profile
Comparing the effect of Aromatase inhibitor (Letrozol) + Cabergoline (Dostinex) and letrozol alone on uterine myoma regression
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 01 Mar 2018
Price :
$35
*
At a glance
- Drugs Cabergoline (Primary) ; Letrozole (Primary)
- Indications Uterine leiomyoma
- Focus Therapeutic Use
- 22 Feb 2018 Status changed from active, no longer recruiting to completed.
- 19 Sep 2016 New trial record